A. Mendes-Pereira

NLK Is a Novel Therapeutic Target for PTEN Deficient Tumour Cells

A. Ashworth, C. Lord, A. Mendes-Pereira, 2012, PloS one.

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

Jung-Sik Kim, Alan Ashworth, A. Ashworth, 2009, EMBO molecular medicine.

Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance

A. Grigoriadis, S. Pettitt, C. Lord, 2022, Oncogene.

Functional viability profiles of breast cancer.

Alan Mackay, Alan Ashworth, Daniel Wetterskog, 2011, Cancer discovery.

High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing

Marketa Zvelebil, Alan Ashworth, Costas Mitsopoulos, 2011, Genome Biology.

PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

A. Ashworth, J. Reis-Filho, R. Natrajan, 2010, Science Translational Medicine.

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen

A. Ashworth, M. Zvelebil, I. Kozarewa, 2011, Proceedings of the National Academy of Sciences.

Synthetic Lethal Targeting of PTEN-Deficient Cancer Cells Using Selective Disruption of Polynucleotide Kinase/Phosphatase

A. Ashworth, Sunita Ghosh, C. Lord, 2013, Molecular Cancer Therapeutics.